Clinical Trials List
2020-01-01 - 2024-12-25
Phase I/II
Terminated5
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Shau-Hsuan Li Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 賴香蘭 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yao-Chung Wu Division of Hematology & Oncology
- Liang-Chih Liu Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
- Chen-Teng Wu Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- San-Chi Chen Division of Hematology & Oncology
- Chung-Pin Li Division of Hematology & Oncology
- Ling-Ming Tseng Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Yun-Cheng Hsieh Division of Hematology & Oncology
- Rheun-Chuan Lee Division of Hematology & Oncology
- Ta-Chung Chao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 劉奕廷 Division of Hematology & Oncology
- Yan-Shen Shan Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- 趙盈瑞 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
50 participants
